PLIANT THERAPEUTICS, INC.: total assets
Total assets for PLIANT THERAPEUTICS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All PLIANT THERAPEUTICS, INC. financial histories
What this measure means
Resources recognized on the balance sheet. Book assets are not the market value of the business.
Exact concept: us-gaap:Assets. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 225,228,000 | USD | 2026-03-11 | 10-K · 0001746473-26-000037 |
| At date | 2024-12-31 | 396,949,000 | USD | 2026-03-11 | 10-K · 0001746473-26-000037 |
| At date | 2023-12-31 | 512,154,000 | USD | 2025-03-03 | 10-K · 0001746473-25-000054 |
| At date | 2022-12-31 | 350,613,000 | USD | 2024-02-27 | 10-K · 0001746473-24-000043 |
| At date | 2021-12-31 | 221,215,000 | USD | 2023-03-09 | 10-K · 0001746473-23-000008 |
| At date | 2020-12-31 | 295,526,000 | USD | 2022-03-01 | 10-K · 0001746473-22-000010 |
| At date | 2019-12-31 | 119,064,000 | USD | 2021-03-16 | 10-K · 0001564590-21-013589 |
Related financial histories
- PLIANT THERAPEUTICS, INC.: total liabilities
- PLIANT THERAPEUTICS, INC.: stockholders equity
- PLIANT THERAPEUTICS, INC.: cash and cash equivalents
- PLIANT THERAPEUTICS, INC.: net income or loss
- PLIANT THERAPEUTICS, INC.: operating cash flow
- PLIANT THERAPEUTICS, INC.: capital expenditure payments
- PLIANT THERAPEUTICS, INC.: contract revenue excluding tax
- PLIANT THERAPEUTICS, INC.: financing cash flow
- PLIANT THERAPEUTICS, INC.: investing cash flow
- PLIANT THERAPEUTICS, INC.: retained earnings or deficit
- PLIANT THERAPEUTICS, INC.: basic weighted-average shares
- PLIANT THERAPEUTICS, INC.: diluted weighted-average shares
- PLIANT THERAPEUTICS, INC.: basic earnings per share
- PLIANT THERAPEUTICS, INC.: diluted earnings per share
- PLIANT THERAPEUTICS, INC.: net property, plant and equipment
- PLIANT THERAPEUTICS, INC.: share-based compensation expense
- PLIANT THERAPEUTICS, INC.: operating income or loss
- PLIANT THERAPEUTICS, INC.: current assets
- PLIANT THERAPEUTICS, INC.: interest expense
- PLIANT THERAPEUTICS, INC.: current liabilities
- PLIANT THERAPEUTICS, INC.: current accounts payable
- PLIANT THERAPEUTICS, INC.: net current accounts receivable
- PLIANT THERAPEUTICS, INC.: operating expenses
- PLIANT THERAPEUTICS, INC.: research and development expense
Inspect the source
- Entity
- PLIANT THERAPEUTICS, INC. / CIK 0001746473
- Captured
- 2026-09-21T17:25:53.377Z
- SEC response SHA-256
8702b02266aa38be05613c25e7cf99b95f2e251695ece0e86ec2ce69e9015c6d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001746473.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))